These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 28591554)
1. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis. Tian R; Zhu Y; Yao J; Meng X; Wang J; Xie H; Wang R Exp Cell Res; 2017 Aug; 357(2):328-334. PubMed ID: 28591554 [TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition. Han Q; Lin L; Zhao B; Wang N; Liu X Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504 [TBL] [Abstract][Full Text] [Related]
4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
5. Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3. Takano M; Yamamoto C; Yamaguchi K; Kawami M; Yumoto R Drug Metab Pharmacokinet; 2015 Feb; 30(1):111-8. PubMed ID: 25760538 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196 [TBL] [Abstract][Full Text] [Related]
7. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo. Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843 [TBL] [Abstract][Full Text] [Related]
8. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling. Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535 [TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition. Xu X; Yuan L; Hu X; Li J; Wu H; Chen F; Huang F; Kong W; Liu W; Xu J; Zhou Y; Zou Y; Shen Y; Guan R; He J; Lu W J Thorac Dis; 2024 Aug; 16(8):4875-4891. PubMed ID: 39268124 [TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation. Wang T; Liu Y; Zou JF; Cheng ZS PLoS One; 2017; 12(9):e0183972. PubMed ID: 28873461 [TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Qian W; Cai X; Qian Q; Zhang W; Wang D J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947 [TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells. Li X; Yan X; Wang Y; Wang J; Zhou F; Wang H; Xie W; Kong H Exp Cell Res; 2018 Jan; 362(2):489-497. PubMed ID: 29258746 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells. Fang LP; Lin Q; Tang CS; Liu XM Pharmacol Res; 2010 Apr; 61(4):298-305. PubMed ID: 19913099 [TBL] [Abstract][Full Text] [Related]
15. Betanin protects against bleomycin-induced pulmonary fibrosis by regulating the NLRP3/IL-1β/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition. Abd Elrazik NA; Helmy SA Food Funct; 2024 Jan; 15(1):284-294. PubMed ID: 38083874 [TBL] [Abstract][Full Text] [Related]
16. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome. Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670 [TBL] [Abstract][Full Text] [Related]
17. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992 [TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [TBL] [Abstract][Full Text] [Related]
19. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis. Zhou W; Mo X; Cui W; Zhang Z; Li D; Li L; Xu L; Yao H; Gao J Sci Rep; 2016 Dec; 6():38646. PubMed ID: 27982105 [TBL] [Abstract][Full Text] [Related]
20. Role of insulin like growth factor axis in the bleomycin induced lung injury in rats. Kotarkonda LK; Kulshrestha R; Ravi K Exp Mol Pathol; 2017 Feb; 102(1):86-96. PubMed ID: 28077319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]